scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YGYNO.2005.10.039 |
P698 | PubMed publication ID | 16376417 |
P2093 | author name string | David Cella | |
Howard T Thaler | |||
David H Moore | |||
Richard P McQuellon | |||
P2860 | cites work | Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study | Q71975328 |
Remission of metastatic cervical adenocarcinoma with weekly paclitaxel | Q73819054 | ||
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study | Q80396730 | ||
General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G) | Q81685445 | ||
Cancer statistics, 2005 | Q29617572 | ||
Using data from studies of health-related quality of life to describe clinical issues examples from a longitudinal study of patients with advanced stages of cervical cancer | Q30597640 | ||
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure | Q34361336 | ||
Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial | Q43998644 | ||
Summary measures and statistics for comparison of quality of life in a clinical trial of cancer therapy. | Q52895249 | ||
Which dimensions of health-related quality of life are altered in patients attending the different gynecologic oncology health care settings? | Q53405292 | ||
Prospective assessment of quality of life of female cancer patients. | Q53443717 | ||
What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592. | Q53450591 | ||
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. | Q53531493 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cisplatin | Q412415 |
paclitaxel | Q423762 | ||
gynecologic oncology | Q5625186 | ||
P304 | page(s) | 296-304 | |
P577 | publication date | 2006-01-10 | |
P1433 | published in | Gynecologic Oncology | Q5625182 |
P1476 | title | Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study. | |
P478 | volume | 101 |